Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,813 | -27,910 | -13,032 | -53,335 | -39,052 |
| Depreciation Amortization | 188 | 126 | 62 | 111 | 85 |
| Accounts payable and accrued liabilities | 22 | -84 | -667 | -48 | -371 |
| Other Working Capital | -2,739 | -3,291 | -4,269 | 1,381 | -1,110 |
| Other Operating Activity | 4,614 | 3,537 | 2,340 | 6,776 | 5,306 |
| Operating Cash Flow | $-38,728 | $-27,622 | $-15,566 | $-45,115 | $-35,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -19 | -14 | -118 | -59 |
| Investing Cash Flow | $-33 | $-19 | $-14 | $-118 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,955 | 4,955 |
| Common Stock Issued | 445 | N/A | 445 | 46,176 | 46,174 |
| Other Financing Activity | 0 | 445 | 0 | 0 | 0 |
| Financing Cash Flow | $445 | $445 | $445 | $51,131 | $51,129 |
| Exchange Rate Effect | -36 | -19 | -3 | -88 | -36 |
| Beginning Cash Position | 106,346 | 106,346 | 106,346 | 100,536 | 100,536 |
| End Cash Position | 67,994 | 79,131 | 91,208 | 106,346 | 116,428 |
| Net Cash Flow | $-38,352 | $-27,215 | $-15,138 | $5,810 | $15,892 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,728 | -27,622 | -15,566 | -45,115 | -35,142 |
| Capital Expenditure | -33 | -19 | -14 | -118 | -59 |
| Free Cash Flow | -38,761 | -27,641 | -15,580 | -45,233 | -35,201 |